Back
The Cigna Group Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
68
CI
The Cigna Group
Last Price:
$330.07
Seasonality Move:
2.66%
Buy
57
SRPT
Sarepta Therapeutics
Last Price:
$53.80
Seasonality Move:
13.2%
Buy
68
The Cigna Group (CI)
is a Buy
Is The Cigna Group a Buy, Sell or Hold?
-
The current The Cigna Group [CI] share price is $330.13. The Score for CI is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
-
CI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $53.79. The Score for SRPT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CI Stock Price Chart
What is The Cigna Group's stock price today?
-
The The Cigna Group share price today is $330.13Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CI is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $53.79Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
CI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.14 | Buy |
Relative Strength Index (14 RSI): | 58.12 | Buy |
Chaikin Money Flow: | 722797 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (317.43 - 330.25) | Buy |
Bollinger Bands (100): | (285.37 - 325.05) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -10.07 | Sell |
Relative Strength Index (14 RSI): | 31.45 | Sell |
Chaikin Money Flow: | -1452145 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (51.97 - 79.33) | Sell |
Bollinger Bands (100): | (79.54 - 128.22) | Sell |
CI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 326.09 | Buy |
20-day SMA: | 325.09 | Buy |
50-day SMA: | 313.16 | Buy |
200-day SMA: | 322.2 | Buy |
8-day EMA: | 327.7 | Buy |
20-day EMA: | 324.38 | Buy |
50-day EMA: | 316.47 | Buy |
200-day EMA: | 316.87 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 52.88 | Buy |
20-day SMA: | 60.79 | Sell |
50-day SMA: | 86.36 | Sell |
200-day SMA: | 118.53 | Sell |
8-day EMA: | 54.47 | Sell |
20-day EMA: | 62.27 | Sell |
50-day EMA: | 80.32 | Sell |
200-day EMA: | 108.23 | Sell |
The Cigna Group Earnings Growth & CI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.75 per share, a decrease next quarter of $0.62 per share, an increase this year of $1.10 per share, and an increase next year of $3.37 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.27 per share, a decrease next quarter of $0.11 per share, an increase this year of $3.98 per share, and an increase next year of $6.27 per share.
The Cigna Group Technical Analysis
Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |